Sylvan Green

1.1k total citations
8 papers, 501 citations indexed

About

Sylvan Green is a scholar working on Oncology, Pharmacology and Physiology. According to data from OpenAlex, Sylvan Green has authored 8 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Pharmacology and 2 papers in Physiology. Recurrent topics in Sylvan Green's work include Pancreatic and Hepatic Oncology Research (2 papers), Inflammatory mediators and NSAID effects (2 papers) and Acute Myeloid Leukemia Research (1 paper). Sylvan Green is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Inflammatory mediators and NSAID effects (2 papers) and Acute Myeloid Leukemia Research (1 paper). Sylvan Green collaborates with scholars based in United States and United Kingdom. Sylvan Green's co-authors include Amanda F. Baker, Tomislav Dragovich, Daniel D. Von Hoff, Pamela R. Hyde, Deborah A. Nichols, Eileen Leary, Clete A. Kushida, James L. Goodwin, James K. Walsh and Daniel J. Gottlieb and has published in prestigious journals such as SLEEP, The Prostate and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Sylvan Green

8 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvan Green United States 8 195 139 134 112 99 8 501
Nicholas Rooney United Kingdom 10 86 0.4× 169 1.2× 40 0.3× 35 0.3× 59 0.6× 16 470
Haris Younas United States 7 181 0.9× 146 1.1× 101 0.8× 37 0.3× 40 0.4× 8 415
R Bucovec Italy 9 67 0.3× 140 1.0× 170 1.3× 16 0.1× 129 1.3× 11 440
P. Lissoni Italy 15 56 0.3× 99 0.7× 125 0.9× 10 0.1× 154 1.6× 34 484
Charlotte Paquet France 6 243 1.2× 264 1.9× 199 1.5× 16 0.1× 34 0.3× 9 610
A Ardizzoia Italy 12 61 0.3× 94 0.7× 123 0.9× 11 0.1× 139 1.4× 31 421
Tatsuya Ihara Japan 11 98 0.5× 111 0.8× 107 0.8× 15 0.1× 38 0.4× 28 351
Ruifang Dong China 10 64 0.3× 212 1.5× 33 0.2× 11 0.1× 73 0.7× 16 422
Yuangao Wang China 9 180 0.9× 290 2.1× 118 0.9× 11 0.1× 46 0.5× 20 603
Yangyang Meng China 9 43 0.2× 77 0.6× 17 0.1× 72 0.6× 62 0.6× 28 292

Countries citing papers authored by Sylvan Green

Since Specialization
Citations

This map shows the geographic impact of Sylvan Green's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvan Green with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvan Green more than expected).

Fields of papers citing papers by Sylvan Green

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvan Green. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvan Green. The network helps show where Sylvan Green may publish in the future.

Co-authorship network of co-authors of Sylvan Green

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvan Green. A scholar is included among the top collaborators of Sylvan Green based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvan Green. Sylvan Green is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Thompson, Patricia A., Denise J. Roe, Julie A. Buckmeier, et al.. (2012). Design and Baseline Characteristics of Participants in a Phase III Randomized Trial of Celecoxib and Selenium for Colorectal Adenoma Prevention. Cancer Prevention Research. 5(12). 1381–1393. 16 indexed citations
2.
Quan, Stuart F., Cynthia Chan, William C. Dement, et al.. (2011). The Association between Obstructive Sleep Apnea and Neurocognitive Performance—The Apnea Positive Pressure Long-term Efficacy Study (APPLES). SLEEP. 34(3). 303–314. 158 indexed citations
3.
Ramanathan, Ramesh K., James L. Abbruzzese, Tomislav Dragovich, et al.. (2010). A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination. Cancer Chemotherapy and Pharmacology. 67(3). 503–509. 104 indexed citations
4.
Thompson, Patricia A., Chiu‐Hsieh Hsu, Sylvan Green, et al.. (2010). Sulindac and Sulindac Metabolites in Nipple Aspirate Fluid and Effect on Drug Targets in a Phase I Trial. Cancer Prevention Research. 3(1). 101–107. 7 indexed citations
5.
Dragovich, Tomislav, Howard A. Burris, Patrick J. Loehrer, et al.. (2008). Gemcitabine Plus Celecoxib in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma. American Journal of Clinical Oncology. 31(2). 157–162. 59 indexed citations
6.
Kushida, Clete A., Deborah A. Nichols, Stuart F. Quan, et al.. (2006). The Apnea Positive Pressure Long-term Efficacy Study (APPLES): Rationale, Design, Methods, and Procedures. Journal of Clinical Sleep Medicine. 2(3). 288–300. 60 indexed citations
7.
List, Alan F., Amanda F. Baker, Sylvan Green, & William Bellamy. (2006). Lenalidomide: Targeted Anemia Therapy for Myelodysplastic Syndromes. Cancer Control. 13(4_suppl). 4–11. 31 indexed citations
8.
Klein, Robert, Susan M. Chambers, Margaret C. Hardy, et al.. (2005). Aurora‐A over‐expression in high‐grade PIN lesions and prostate cancer. The Prostate. 64(4). 341–346. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026